242 related articles for article (PubMed ID: 29515780)
1. Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.
Yamada S; Takashina Y; Watanabe M; Nagamine R; Saito Y; Kamada N; Saito H
Oncotarget; 2018 Feb; 9(11):9925-9939. PubMed ID: 29515780
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
[TBL] [Abstract][Full Text] [Related]
3. Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model.
Yamada S; Kimura M; Saito Y; Saito H
J Clin Biochem Nutr; 2018 Sep; 63(2):123-128. PubMed ID: 30279623
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota, fatty liver disease, and hepatocellular carcinoma.
Chu H; Williams B; Schnabl B
Liver Res; 2018 Mar; 2(1):43-51. PubMed ID: 30416839
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
[TBL] [Abstract][Full Text] [Related]
7. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y
Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843
[TBL] [Abstract][Full Text] [Related]
8. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes.
Xie G; Wang X; Zhao A; Yan J; Chen W; Jiang R; Ji J; Huang F; Zhang Y; Lei S; Ge K; Zheng X; Rajani C; Alegado RA; Liu J; Liu P; Nicholson J; Jia W
Sci Rep; 2017 Mar; 7():45232. PubMed ID: 28345673
[TBL] [Abstract][Full Text] [Related]
9. An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors.
Ponnusamy S; Tran QT; Thiyagarajan T; Miller DD; Bridges D; Narayanan R
Exp Biol Med (Maywood); 2017 Mar; 242(6):606-616. PubMed ID: 28092182
[TBL] [Abstract][Full Text] [Related]
10. Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation.
Shu X; Li M; Cao Y; Li C; Zhou W; Ji G; Zhang L
Front Pharmacol; 2021; 12():750826. PubMed ID: 34603061
[TBL] [Abstract][Full Text] [Related]
11. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC.
Kroh A; Walter J; Fragoulis A; Möckel D; Lammers T; Kiessling F; Andruszkow J; Preisinger C; Egbert M; Jiao L; Eickhoff RM; Heise D; Berndt N; Cramer T; Neumann UP; Egners A; Ulmer TF
Neoplasia; 2023 Dec; 46():100945. PubMed ID: 37976569
[TBL] [Abstract][Full Text] [Related]
14. Distinctly altered gut microbiota in the progression of liver disease.
Xie G; Wang X; Liu P; Wei R; Chen W; Rajani C; Hernandez BY; Alegado R; Dong B; Li D; Jia W
Oncotarget; 2016 Apr; 7(15):19355-66. PubMed ID: 27036035
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis.
Liakina V; Strainiene S; Stundiene I; Maksimaityte V; Kazenaite E
World J Hepatol; 2022 Jul; 14(7):1277-1290. PubMed ID: 36158907
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
17. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice.
Cao Y; Pan Q; Cai W; Shen F; Chen GY; Xu LM; Fan JG
Arch Iran Med; 2016 Mar; 19(3):197-203. PubMed ID: 26923892
[TBL] [Abstract][Full Text] [Related]
20. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota.
Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X
J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
